DNDi
The Drugs for Neglected Diseases initiative
The client
The Drugs for Neglected Diseases initiative (DNDi) was born out of the frustration of doctors from Médecins Sans Frontières (MSF) who found themselves unable to treat patients suffering from tropical diseases because of a lack of suitable drugs.
The challenge
As part of this ambitious fundraising goal, DNDi wished to attract significantly greater philanthropic support from private sector donors. Whilst the organisation had developed a clear and detailed plan for increasing funding from these donors, they needed compelling fundraising materials that would resonate with this new audience and effectively communicate DNDi’s unique model and life-saving impact.
Solution
We applied our Discovery Process to understand how DNDi was perceived by key stakeholder groups – including existing private donors, supporters and external advisers – and how those within the organisation would present the story. We also identified internal and external factors that might influence the potential for this fundraising to be realised.
The findings from this comprehensive research were then used to inform the development of a range of new fundraising materials tailored specifically to engage private sector philanthropists and support DNDi’s €600 million fundraising ambition.
